Does ABIRATERONE Cause Product dose omission issue? 170 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 170 reports of Product dose omission issue have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.5% of all adverse event reports for ABIRATERONE.
170
Reports of Product dose omission issue with ABIRATERONE
0.5%
of all ABIRATERONE reports
7
Deaths
44
Hospitalizations
How Dangerous Is Product dose omission issue From ABIRATERONE?
Of the 170 reports, 7 (4.1%) resulted in death, 44 (25.9%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 170 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ABIRATERONE Alternatives Have Lower Product dose omission issue Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB